Correvio: 3Q Earnings Snapshot

November 14, 2019 GMT

VANCOUVER, British Columbia (AP) _ Correvio Pharma Corp. (CORV) on Thursday reported a loss of $10.8 million in its third quarter.

The Vancouver, British Columbia-based company said it had a loss of 23 cents per share.

The results missed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 17 cents per share.

The cardiovascular drug maker posted revenue of $6.7 million in the period, which also fell short of Street forecasts. Three analysts surveyed by Zacks expected $8.9 million.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CORV at https://www.zacks.com/ap/CORV